Article: Statins may reduce risk of colorectal cancer.(Across Specialties)

NEW ORLEANS -- Data from a large epidemiological study suggest that colorectal cancer may soon join the list of conditions that can be ameliorated by HMG-CoA reductase inhibitors.

Regular use of statins for prevention of cardiovascular disease was associated with a nearly 50% reduction in the prevalence of colorectal cancer, according to findings presented at the annual meeting of the American Society of Clinical Oncology.

"Our data cannot be used as rationale for changing the indication for statin drugs to include prevention or treatment of colorectal cancer, but this question certainly warrants further investigation," said Jenny Poynter, a statistician ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!